- Pre-clinical development of patented lead compounds for tumor targeting and microbial infections
- Identification of new targets (tumor and bacterial markers)
- Scale up and optimization of peptide synthesis
- Lead peptide identification/discovery
- Strategic collaborations and joint venture agreements
Welcome to SetLance
SetLance focuses on the development of peptide-based drugs for the treatment of cancer and infectious diseases.
Our address
SetLance
Via Fiorentina, 1
53100 Siena
Italy
Phone: +39 0577 234928
Fax: +39 0577 234921
E-Mail: info@setlance.com